MISSIONPHARMA A/S

CVR 26902398 · Public limited company (A/S) · Active · Low risk

MISSIONPHARMA A/S is a Public limited company (A/S), founded on , based in Lynge. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.0% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Mar 2026) shows equity of DKK 317.8m and a net result of DKK 120.2m. CEO: Edouard Marc Marie Favreau.

Bankruptcy risk for MISSIONPHARMA A/S

0.0%
probability of bankruptcy within 12 months
Low risk

0.0 × the average (1.41%) · higher risk than 6% of active Danish companies

Lowest riskHighest risk

Increases the risk

CEO changes in the last year2+ · bankruptcy rate 18.5%2.1×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Time since new CEO< 0.5 yrs · bankruptcy rate 11.6%1.3×

Reduces the risk

Reporting classReporting class C, large enterprise · bankruptcy rate 0.2%0.03×
Age (years)20+ yrs · bankruptcy rate 2.0%0.23×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Equity ratio60%+ · bankruptcy rate 3.3%0.38×
Current ratio200%–500% · bankruptcy rate 3.4%0.39×
Number of auditors (historical)3+ · bankruptcy rate 3.7%0.42×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
26902398
Status
Active
Company type
Public limited company (A/S)
Founded
(23 years)
Address
Vassingerødvej 9
3540 Lynge
Municipality
Allerød
Industry
Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr
Share capital
DKK 2.1m
Employees
60 (2018)
Auditor
Forvis Mazars Statsautoriseret Revisionspartnerselskab
Audit opted out
No

Warning signs

Annual reports filed late0 of 23
Missing annual reportNo
Negative equityNo
Equity ratio68.4%
Current ratio314%
Moves (last 2 years)0
CEO changes in total9
CEO's previous bankruptcies0
Other companies at the address8
Going-concern uncertaintyNo

Financials and key figures

Financial year20262025
RevenueDKK 934.5mDKK 742.0m
Gross profitDKK 220.7mDKK 148.0m
Net profitDKK 120.2mDKK 73.4m
EquityDKK 317.8mDKK 273.1m
Total assetsDKK 464.9mDKK 403.2m
CashDKK 32.3m–
Short-term debtDKK 126.5m–
Avg. employees62–

Latest annual report: Reporting class C, large enterprise · auditor's statement: Auditor's report on audited financial statements · FORVIS MAZARS Statsautoriseret Revisionspartnerselskab.

Filed annual reports

Reporting periodPublishedDays after period end
1 Apr 2025 – 31 Mar 202689
1 Apr 2024 – 31 Mar 202592
1 Apr 2023 – 31 Mar 202492
1 Apr 2022 – 31 Mar 202397
1 Apr 2021 – 31 Mar 202299
1 Apr 2020 – 31 Mar 2021106
1 Apr 2019 – 31 Mar 202098
1 Apr 2018 – 31 Mar 2019101
1 Jan 2017 – 31 Dec 2017165
1 Jan 2016 – 31 Dec 2016152
1 Jan 2015 – 31 Dec 2015151
1 Jan 2014 – 31 Dec 2014139
1 Jan 2013 – 31 Dec 2013155
1 May 2011 – 30 Apr 201286
1 May 2010 – 30 Apr 2011156
1 May 2009 – 30 Apr 2010153
1 May 2008 – 30 Apr 2009150
1 May 2007 – 30 Apr 2008153
1 May 2006 – 30 Apr 200765
1 May 2005 – 30 Apr 200663

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOEdouard Marc Marie FavreauCurrent
CEOKim Erik Ginnerup
CEOErik Schou Stavnstrup
CEOPoul Lindof
CEOChristian Ilsøe
CEOPoul Lindof
CEOAlexandre Pierre Jean Vialatte
BoardKim Erik GinnerupCurrent
BoardIlona Maureen FischerCurrent
BoardJean-Marc Pierre René LecciaCurrent
BoardEric Pierre Jean MurisCurrent
BoardLeif Ole Lund-Andersen
BoardKim Erik Ginnerup
BoardErik Schou Stavnstrup
BoardAlan Per Binau
BoardJesper Ahlmann Funding Andersen
BoardPaule Georgette Ginnerup
BoardHenning Brømsøe Termansen
BoardPeter Normann
BoardLeif Ole Lund-Andersen
BoardEric Pierre Jean Muris
BoardKim Erik Ginnerup
BoardJean-Marc Pierre René Leccia
BoardDenis Georges Fernand Maurice
BoardAnnie Renée Simonne Dateu
BoardAymeric Erouart
BoardPatricia Hec
Owner (100%)CFAO HEALTHCARE SACurrent
Owner (50%)P. GINNERUP ApS
Owner (100%)MISSIONPHARMA GROUP ApS
AuditorForvis Mazars Statsautoriseret RevisionspartnerselskabCurrent
AuditorNIELS HARDER A/S
AuditorEY Danmark A/S
AuditorERNST & YOUNG DENMARK P/S
AuditorEY Godkendt Revisionspartnerselskab
AuditorKPMG P/S
AuditorPRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB
FounderMISSIONPHARMA HOLDING A/SCurrent

The CEOs' other companies

Kim Erik Ginnerup – 33 other companies, of which 1 bankrupt

Erik Schou Stavnstrup – 10 other companies

Poul Lindof – 15 other companies, of which 3 bankrupt

Christian Ilsøe – 13 other companies, of which 2 bankrupt

Alexandre Pierre Jean Vialatte – 3 other companies

Address history (0 moves)

Vassingerødvej 9, 3540 Lynge

Employees per year

Number of employees at MISSIONPHARMA A/S per year30602011: 5220112012: 5120122013: 3820132014: 4920142015: 5120152016: 6020162017: 5720172018: 602018

Other companies at the same address

Similar companies in Allerød

Questions and answers about MISSIONPHARMA A/S

Has MISSIONPHARMA A/S gone bankrupt?

No, MISSIONPHARMA A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of MISSIONPHARMA A/S?

Our model estimates a bankruptcy risk of 0.0% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.

Who is the CEO of MISSIONPHARMA A/S?

Edouard Marc Marie Favreau is the CEO of MISSIONPHARMA A/S.

Who is the auditor of MISSIONPHARMA A/S?

MISSIONPHARMA A/S most recently used Forvis Mazars Statsautoriseret Revisionspartnerselskab.

When was MISSIONPHARMA A/S founded?

MISSIONPHARMA A/S was founded on 6 December 2002.

What is the equity of MISSIONPHARMA A/S?

Equity was DKK 317.8m according to the annual report for the period ending 31 March 2026.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.